These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8864494)

  • 1. Effects of bromocriptine and/or L-DOPA on neurons in substantia nigra of MPTP-treated C57BL/6 mice.
    Fukuda T; Watabe K; Tanaka J
    Brain Res; 1996 Jul; 728(2):274-6. PubMed ID: 8864494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
    J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
    Schneider JS; Kean A; DiStefano L
    J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Pearce RK; Banerji T; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
    Bian GL; Wei LC; Shi M; Wang YQ; Cao R; Chen LW
    Brain Res; 2007 May; 1150():55-61. PubMed ID: 17397812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
    Melamed E; Rosenthal J; Globus M; Cohen O; Uzzan A
    Brain Res; 1985 Sep; 342(2):401-4. PubMed ID: 3876139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Muralikrishnan D; Mohanakumar KP
    FASEB J; 1998 Jul; 12(10):905-12. PubMed ID: 9657530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Nishi K
    Brain Res; 1997 Oct; 771(1):133-41. PubMed ID: 9383016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
    Smith LA; Jackson MJ; Hansard MJ; Maratos E; Jenner P
    Mov Disord; 2003 May; 18(5):487-95. PubMed ID: 12722161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynostemma pentaphyllum Ethanolic Extract Protects Against Memory Deficits in an MPTP-Lesioned Mouse Model of Parkinson's Disease Treated with L-DOPA.
    Kim KS; Zhao TT; Shin KS; Park HJ; Cho YJ; Lee KE; Kim SH; Lee MK
    J Med Food; 2017 Jan; 20(1):11-18. PubMed ID: 28005447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.
    Klemann CJHM; Xicoy H; Poelmans G; Bloem BR; Martens GJM; Visser JE
    Mol Neurobiol; 2018 Jul; 55(7):5639-5657. PubMed ID: 29019056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
    Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
    Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUNEL-positive cells in the substantia nigra of C57BL/6 mice after a single bolus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Spooren WP; Gentsch C; Wiessner C
    Neuroscience; 1998 Jul; 85(2):649-51; discussion 653. PubMed ID: 9622260
    [No Abstract]   [Full Text] [Related]  

  • 20. SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons.
    Neff NH; Wemlinger TA; Hadjiconstantinou M
    J Neural Transm (Vienna); 2000; 107(4):429-43. PubMed ID: 11215754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.